Joel Greenblatt fit · Magic Formula - high ROIC + cheap EV/EBIT
Is Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
40/100
DMixed signals
1/5 criteria passed
Joel Greenblatt's Criteria, Applied to PHAR
EBIT/EV yield ≥ 10%
key2.2%
ROIC ≥ 25%
key-2.6%
EV/EBIT ≤ 12
44.6x
Gross margin ≥ 30%
89.9%
Earnings yield ≥ 6%
0.0%
How PHAR Scores on Other Strategies
Live Financial Snapshot
Market cap
$889.88M
P/E (TTM)
77.6x
ROIC (TTM)
3.76%
Gross margin
88.12%
Other Joel Greenblatt fit reports
Frequently Asked Questions
What is PHAR's Joel Greenblatt fit score?
PHAR scores 40/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own PHAR?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends PHAR.
How often is this score updated?
PHAR's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Joel Greenblatt personally owns or recommends PHAR.